In a patient with chronic atrial fibrillation on warfarin for seven years undergoing transurethral resection of bladder tumor (TURBT), is the procedure considered intermediate or high risk for bleeding?

TURBT is a High-Risk Bleeding Procedure

TURBT (transurethral resection of bladder tumor) is classified as a high-risk bleeding procedure in patients on anticoagulation, requiring warfarin discontinuation 3-5 days preoperatively. 1

Risk Classification

The ICUD/AUA guidelines explicitly state that "AC/AP in patients undergoing TURP is associated with an increased risk of bleeding" and categorize these transurethral resections as high-risk procedures 1. While this statement specifically mentions TURP, TURBT falls into the same category of transurethral resections with similar bleeding risk profiles.

Perioperative Warfarin Management for TURBT

Preoperative Management

• Stop warfarin 3-5 days before surgery 1
• Target INR < 1.5 before the procedure 1
• The 5-day interruption period is supported by the 2022 CHEST guidelines for VKA interruption 2

Postoperative Management

• Resume warfarin 12-24 hours after surgery if adequate hemostasis is achieved 2, 1
• The CHEST guidelines suggest resuming within 24 hours (typically evening of surgery) over delayed resumption 2

Bridging Considerations

For your patient with 7 years of chronic atrial fibrillation:

• Assess thromboembolic risk using CHA₂DS₂-VASc score
• High-risk patients (CHA₂DS₂-VASc ≥5, recent stroke/TIA within 3 months, mechanical valve) may require bridging with heparin
• Lower-risk AF patients typically do not require bridging therapy
• The decision requires balancing stroke risk against the documented increased bleeding risk with TURBT 1

Evidence on Bleeding Risk

Recent data confirms TURBT carries significant bleeding complications in anticoagulated patients:

• Bleeding requiring re-catheterization occurs in approximately 10-13% of anticoagulated patients 3
• Re-intervention for bleeding needed in 6-7% 3
• Blood transfusion rates are 2-3% 3
• Overall complication rates reach 23% in some series, with bleeding being the most common (14%) 4

Critical Pitfalls to Avoid

1. Do not continue warfarin through TURBT - Unlike ureteroscopy (which can be performed on anticoagulation), TURBT requires interruption 1
2. Do not use the < 5-day interruption period - Insufficient time for INR normalization increases bleeding risk
3. Verify INR < 1.5 before proceeding - Elderly patients and those on low warfarin doses may need longer interruption 2
4. All bleeding complications occur within 2 weeks - This marks the high-risk period for hemorrhagic events 3

The classification as high-risk is consistent across urological guidelines and reflects the vascular nature of bladder tumors and the inability to achieve direct compression hemostasis in the bladder 1.